Folly of FDA-approval studies for bone morphogenetic protein
- PMID: 21729798
- DOI: 10.1016/j.spinee.2011.05.009
Folly of FDA-approval studies for bone morphogenetic protein
Comment on
-
A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.Spine J. 2011 Jun;11(6):471-91. doi: 10.1016/j.spinee.2011.04.023. Spine J. 2011. PMID: 21729796
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical